Abivax S.A. (ABVX)

R&D Expense Growth

31.39%

Quarterly · Period ending:

ABVX logo

ABVX R&D Expense Growth

Latest reported31.39%
ABVX Quarterly R&D Growth (QoQ) (0.00% → 31.39%)
High-resolution chart · PNG

ABVX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Abivax S.A. R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
31.3881%
14.8894%
-1.6692%
35.9567%
-59.0285%
116.2774%
-0.6608%
117.3761%
-35.0153%
-2.9555%
13.7572%
56.3558%
-3.9783%
-6.3747%
70.1033%
24.7274%
37.991%
-10.6825%
-8.3946%
-32.0587%
10.7968%
19.385%
84.8831%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.